Subscribe
shutterstock_1463056853_poptika
Poptika / Shutterstock.com
22 June 2021BiotechnologyLinda Thayer, Aaron Capron and Sneha Nyshadham

Navigating patent eligibility in digital healthcare

Digital healthcare technologies are transforming the healthcare industry and quickly changing the way healthcare is delivered. Disruptive technologies such as artificial intelligence, together with faster processing devices, have made it possible to analyse and predict risk and outcomes, sometimes in real time.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
It’s time to review patent eligibility for diagnostic methods
27 June 2023   More clarity is needed on the application of Alice and Mayo to patent eligibility—particularly for firms developing innovative medical diagnostic techniques, say Kara Specht and Yinan Liu of Finnegan.


Editor's picks

Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024

Editor's picks

Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024

More on this story

Medtech
It’s time to review patent eligibility for diagnostic methods
27 June 2023   More clarity is needed on the application of Alice and Mayo to patent eligibility—particularly for firms developing innovative medical diagnostic techniques, say Kara Specht and Yinan Liu of Finnegan.

More on this story

Medtech
It’s time to review patent eligibility for diagnostic methods
27 June 2023   More clarity is needed on the application of Alice and Mayo to patent eligibility—particularly for firms developing innovative medical diagnostic techniques, say Kara Specht and Yinan Liu of Finnegan.

More features

Moderna wins reprieve in COVID-19 vaccine dispute
UK judge ends J&J unit’s hopes of reviving Stelara patent
‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards
‘I’m breaking new ground’: Mölnlycke’s first TM attorney charts a new course
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
Preventative IP for preventative pharma healthcare
Court denies Regeneron bid to halt copy of blockbuster eye drug
Gilead scores win in fake HIV drug dispute